Eight teams ready for Saudi Premiere League Season-2

Kuwait: Eid is usually a time of family get-togethers and feasts after weeks of dawn-to-dusk fasting. But this year people celebrated at home, with virus fears dampening the holiday spirit and strict restrictions in place.

Kuwait went under full curfew before the start of Ramadan leaving people to practice fasting and Ramadan rituals at home, Even Eid al-Fitr came under full lock-down period.

As situation demanded, IMA Kuwait celebrated the Eid Get-together online via video conferencing tool, All IMA members participated joyfully in Eid Milan online gathering which was scheduled immediately after Eid prayer. Members participated and congratulated each other on the eve of Eid.

The IMA president Shamvel Parviz addressed the gathering and thanked them for joining online for this unique Eid celebration which will be remembered in history. He also advised members to be aware of conditions of neighbors, friends and family and assist them if they need help in this difficult time.

Eid al-Fitr follows weeks of fasting and marks the end of the holy month of Ramadan. Thousands of Muslims all over Kuwait followed strict guideline and performed Eid prayer at home along with their family.

As a part of social service activities IMA also distributed ration kits before start of Ramadan and during Ramadan for needy people all over Kuwait.

Farukkhabad, Jan 14: In a shocking incident, a new-born baby was mauled to death by a dog inside the operation theatre (OT) of a private hospital in Farukkhabad on Monday.

Family members of the baby boy said that they noticed the hospital staff shooing a dog away from inside the operation theatre and soon after, they were told the baby boy, born just two hours ago, was dead.

The family members said that they found the baby's body on the floor and it had deep gashes around the neck and other parts of the body.

District magistrate Manvendra Singh has ordered an FIR and the Chief Medical Officer (CMO) Chandra Shekhar said the hospital has been sealed and an inquiry ordered into the incident.

Sources said that the hospital where the incident took place was unregistered and was being run adjacent to a government hospital.

According to the FIR lodged with Sadar Kotwali police, the infant's father Ravi Kumar said he had admitted his wife Kanchan in the hospital on Monday and she was taken for a C-section to the operation theatre.

After the delivery, Kanchan was shifted to the ward but the family was told that the baby would be shifted later.

An hour later, the family was informed that the baby had died.

The family members then saw the hospital staff trying to chase a dog out of the operation theatre.

The family members forced their way into the operation theatre and found the infant lying on the floor with several injuries on the neck.

The police said that the baby's body has been preserved for examination and post mortem.

The FIR has been registered against Dr Mohit Gupta, and some of the staff members who were present during the delivery.

The hospital owner, Vijay Patel, however, feigned complete ignorance about the incident and said that he had been told that the baby was born dead.

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.